ID

12961

Description

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193024

Link

https://clinicaltrials.gov/show/NCT00193024

Keywords

  1. 1/7/16 1/7/16 -
Uploaded on

January 7, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00193024

Eligibility Breast Cancer NCT00193024

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
metastatic breast cancer confirmed by biopsy.
Description

biopsy metastasis

Data type

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C0027627
received no previous chemotherapy for metastatic breast cancer.
Description

chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
prior hormonal therapy is acceptable.
Description

hormone therapy

Data type

boolean

Alias
UMLS CUI [1]
C0279025
measurable or evaluable disease.
Description

measurement, evaluation

Data type

boolean

Alias
UMLS CUI [1]
C0242485
UMLS CUI [2]
C0220825
able to perform activities of daily living without considerable assistance
Description

performance status

Data type

boolean

Alias
UMLS CUI [1]
C1518965
adequate bone marrow, liver and kidney function
Description

organ function

Data type

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0005953
UMLS CUI [3]
C0232804
must be able to understand the nature of this study and give written informed consent.
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
age < 18 years.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
cardiac ejection fraction < 45%.
Description

cardiac ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0232174
women who are pregnant or lactating.
Description

pregnancy, lactating

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C2828358
patients with meningeal metastases are ineligible.
Description

meningeal metastasis

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0025284
moderate peripheral neuropathy
Description

peripheral neuropathy

Data type

boolean

Alias
UMLS CUI [1]
C0031117
history of hypersensitivity reaction to taxotere
Description

hypersensitivity

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0699967
males with metastatic breast cancer
Description

gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

additional inclusion/exclusion criteria

Data type

boolean

Similar models

Eligibility Breast Cancer NCT00193024

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
biopsy metastasis
Item
metastatic breast cancer confirmed by biopsy.
boolean
C0005558 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
chemotherapy
Item
received no previous chemotherapy for metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1])
hormone therapy
Item
prior hormonal therapy is acceptable.
boolean
C0279025 (UMLS CUI [1])
measurement, evaluation
Item
measurable or evaluable disease.
boolean
C0242485 (UMLS CUI [1])
C0220825 (UMLS CUI [2])
performance status
Item
able to perform activities of daily living without considerable assistance
boolean
C1518965 (UMLS CUI [1])
organ function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
informed consent
Item
must be able to understand the nature of this study and give written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
age
Item
age < 18 years.
boolean
C0001779 (UMLS CUI [1])
cardiac ejection fraction
Item
cardiac ejection fraction < 45%.
boolean
C0232174 (UMLS CUI [1])
pregnancy, lactating
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
meningeal metastasis
Item
patients with meningeal metastases are ineligible.
boolean
C0027627 (UMLS CUI [1,1])
C0025284 (UMLS CUI [1,2])
peripheral neuropathy
Item
moderate peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
hypersensitivity
Item
history of hypersensitivity reaction to taxotere
boolean
C0020517 (UMLS CUI [1,1])
C0699967 (UMLS CUI [1,2])
gender
Item
males with metastatic breast cancer
boolean
C0079399 (UMLS CUI [1])
additional inclusion/exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial